Literature DB >> 1801345

Toxoplasma antibodies in HIV-positive patients from Nairobi.

R Brindle1, R Holliman, C Gilks, P Waiyaki.   

Abstract

Sera from 94 patients infected with human immunodeficiency virus (HIV) 1, together with 86 controls, attending the Kenyatta National Hospital, Nairobi were examined for antibodies to Toxoplasma gondii using enzyme immunoassay and latex and dye tests. 54% had Toxoplasma-specific immunoglobulin G (IgG) by dye test. 22% of the HIV-positive group had IgG levels in excess of 180 units/ml (approximating to a dye test titre of 1:1300) compared to 1% of the HIV-negative group. There was no correlation between high levels of IgG and clinical stage of HIV disease or features indicative of active toxoplasmosis. It is proposed that the elevated serum IgG is a reflection of early Toxoplasma reactivation, not necessarily associated with disease.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Antibodies; Biology; Case Control Studies; Central Nervous System; Central Nervous System Effects; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Hematologic Tests; Hiv Infections; Immunity; Immunologic Factors; Kenya; Laboratory Examinations And Diagnoses; Laboratory Procedures; Methodological Studies; Parasitic Diseases; Physiology; Research Methodology; Retrospective Studies; Studies; Viral Diseases

Mesh:

Substances:

Year:  1991        PMID: 1801345     DOI: 10.1016/0035-9203(91)90443-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

1.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

2.  The probability of acquiring primary Toxoplasma infection in HIV-infected patients: results of an 8-year retrospective study.

Authors:  I Reiter-Owona; R Bialek; J K Rockstroh; H M Seitz
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

Review 3.  Recent advances in Toxoplasma gondii immunotherapeutics.

Authors:  Sherene Swee-Yin Lim; Rofina Yasmin Othman
Journal:  Korean J Parasitol       Date:  2014-12-23       Impact factor: 1.341

Review 4.  A Review on the Present Advances on Studies of Toxoplasmosis in Eastern Africa.

Authors:  John Mokua Mose; John Maina Kagira; David Muchina Kamau; Naomi Wangari Maina; Maina Ngotho; Simon Muturi Karanja
Journal:  Biomed Res Int       Date:  2020-07-06       Impact factor: 3.411

5.  Introduction of protocols for mass production of Toxoplasma gondii tachyzoites of the genotype II PRU strain.

Authors:  Mohammad Saleh Bahreini; Mohammad Nohtani; Amir Masoud Salemi; Mehdi Mirzaeipour; Naghmeh Dastan; Sara Bajelan; Qasem Asgari
Journal:  Animal Model Exp Med       Date:  2021-06-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.